At Mentavi Health, our goal is to make comprehensive virtual mental health assessments more accessible to patients nationwide, evaluating for and diagnosing ADHD and other conditions such as anxiety, depression, and OCD.
The data from our landmark validation study* for diagnosing ADHD in Adults marks a significant milestone in the evolution of credible, clinical mental health assessment and treatment in the telehealth space.
About the study
“Presenting this data at the World Congress on ADHD — to many of the world’s foremost experts in the field — represents a pivotal moment for advancing both the diagnosis of adult ADHD and the clinical credibility of telehealth.”
— Keith Brophy, CEO, Mentavi Health
With scientific rigor and clinical oversight, we created a study comparing our Diagnostic Evaluation to the current standard of care for ADHD diagnosis of adults, a face-to-face clinical interview by a trained mental health clinician applying DSM-5 criteria.
The study set out to prove that our digital evaluation could deliver the same accuracy as a traditional clinical interview, only in more convenient, widely accessible ways.
Why clinical validation matters
Adult ADHD remains significantly underdiagnosed and untreated due to barriers such as cost, geography, stigma, and clinician shortages, leaving people without answers or support.
While telehealth evaluations address those gaps in diagnosis and treatment, they also garner a fair amount of skepticism. Many remain hesitant over concerns about accuracy and reliability Can an online-only solution really deliver the same results as traditional methods?
Put simply, yes. The results showed that the Mentavi Mental Health Diagnostic Evaluation is as effective as traditional methods in diagnosing ADHD in adults.
Methods and findings
A total of 345 participants were selected from a pool of more than 2,000 adults seeking online ADHD evaluations for a side-by-side comparison between a secure Zoom-based clinical interview with a licensed psychologist and our asynchronous Diagnostic Evaluation.
The findings revealed a strong 78% agreement rate between the two methods, particularly for ADHD positive cases. The study also showed that the Diagnostic Evaluation demonstrated
- A 94.9% Positive Predictive Value (PPV) for ADHD positive cases.
- A false positive rate of 12% versus 56% for the clinical interview.
- A more conservative rate of diagnosis, suggesting overdiagnosis with our Diagnostic Evaluation is not occurring. In cases where a definitive diagnosis was not confirmed, a recommendation for further evaluation was offered.
The future of mental health treatment
“This study validates that rigorously developed asynchronous tools can deliver diagnostic outcomes comparable to traditional methods, enabling timely, scalable access to high-quality care.”
— Barry K. Herman, MD, MMM, Chief Medical Officer
Virtual mental health evaluations are not just convenient and accessible — we’ve demonstrated that they’re also credible and accurate. These findings reinforce our belief in and commitment to evidence-based, thoughtfully designed digital tools that not only deliver reliable results but foster more widespread adoption of telehealth solutions.
Partnering for better outcomes
We’re here to help your patients, members, employees, and students thrive. Together, we can continue making the future of mental health care more accessible, affordable, and streamlined for all.
To learn more about partnership opportunities with Mentavi Health, visit Mentavi.com/contactus.
*Diagnostic evaluation is clinically validated for the diagnosis of ADHD in Adults. Study results presented at the 2025 ADHD World Congress.
